Addex Therapeutics Ltd announced that it has received CHF 2,700,000 in a round of funding on August 3, 2023. The transaction included participation from returning investor Indivior PLC.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,446 GBX | +0.73% | +0.49% | +22.11% |
05-03 | Deutsche Bank Kicks Off Indivior Coverage at Buy | MT |
05-03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,446 GBX | +0.73% | +0.49% | 2.43B | ||
0.0734 CHF | +3.38% | +20.33% | 10.37M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.11% | 2.43B | |
+6.80% | 72.03B | |
-10.86% | 5.14B | |
+46.43% | 4.6B | |
+5.38% | 3.96B | |
-16.20% | 2.5B | |
-26.20% | 2.32B | |
+19.92% | 2.18B | |
+8.15% | 1.72B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- INDV Stock
- News Indivior PLC
- Addex Therapeutics Ltd announced that it has received CHF 2.7 million in funding from Indivior PLC